LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
- PMID: 23042116
- DOI: 10.1038/ng.2436
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
Abstract
LIN28B regulates developmental processes by modulating microRNAs (miRNAs) of the let-7 family. A role for LIN28B in cancer has been proposed but has not been established in vivo. Here, we report that LIN28B showed genomic aberrations and extensive overexpression in high-risk neuroblastoma compared to several other tumor entities and normal tissues. High LIN28B expression was an independent risk factor for adverse outcome in neuroblastoma. LIN28B signaled through repression of the let-7 miRNAs and consequently resulted in elevated MYCN protein expression in neuroblastoma cells. LIN28B-let-7-MYCN signaling blocked differentiation of normal neuroblasts and neuroblastoma cells. These findings were fully recapitulated in a mouse model in which LIN28B expression in the sympathetic adrenergic lineage induced development of neuroblastomas marked by low let-7 miRNA levels and high MYCN protein expression. Interference with this pathway might offer therapeutic perspectives.
Similar articles
-
Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma.Nature. 2016 Jul 14;535(7611):246-51. doi: 10.1038/nature18632. Epub 2016 Jul 6. Nature. 2016. PMID: 27383785 Free PMC article.
-
Lin28B and Let-7 in the Control of Sympathetic Neurogenesis and Neuroblastoma Development.J Neurosci. 2015 Dec 16;35(50):16531-44. doi: 10.1523/JNEUROSCI.2560-15.2015. J Neurosci. 2015. PMID: 26674877 Free PMC article.
-
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma.Cancer Lett. 2015 Sep 28;366(1):123-32. doi: 10.1016/j.canlet.2015.06.015. Epub 2015 Jun 26. Cancer Lett. 2015. PMID: 26123663 Free PMC article.
-
MYCN/LIN28B/Let-7/HMGA2 pathway implicated by meta-analysis of GWAS in suppression of post-natal proliferation thereby potentially contributing to aging.Mech Ageing Dev. 2013 Jul-Aug;134(7-8):346-8. doi: 10.1016/j.mad.2013.04.006. Epub 2013 Apr 29. Mech Ageing Dev. 2013. PMID: 23639551 Review.
-
The MYCN oncoprotein as a drug development target.Cancer Lett. 2003 Jul 18;197(1-2):125-30. doi: 10.1016/s0304-3835(03)00096-x. Cancer Lett. 2003. PMID: 12880971 Review.
Cited by
-
N6-methyladenosine modification of circMARK2 enhances cytoplasmic export and stabilizes LIN28B, contributing to the progression of Wilms tumor.J Exp Clin Cancer Res. 2024 Jul 11;43(1):191. doi: 10.1186/s13046-024-03113-9. J Exp Clin Cancer Res. 2024. PMID: 38987793 Free PMC article.
-
The RNA-binding protein LIN28B regulates developmental timing in the mammalian cochlea.Proc Natl Acad Sci U S A. 2015 Jul 21;112(29):E3864-73. doi: 10.1073/pnas.1501077112. Epub 2015 Jul 2. Proc Natl Acad Sci U S A. 2015. PMID: 26139524 Free PMC article.
-
Histone deacetylase 10 promotes autophagy-mediated cell survival.Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):E2592-601. doi: 10.1073/pnas.1300113110. Epub 2013 Jun 25. Proc Natl Acad Sci U S A. 2013. PMID: 23801752 Free PMC article.
-
LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR).Acta Neuropathol. 2012 Dec;124(6):875-81. doi: 10.1007/s00401-012-1068-3. Epub 2012 Nov 16. Acta Neuropathol. 2012. PMID: 23161096 Free PMC article.
-
The zebrafish as a model for studying neuroblastoma.Cancer Cell Int. 2016 Nov 3;16:82. doi: 10.1186/s12935-016-0360-z. eCollection 2016. Cancer Cell Int. 2016. PMID: 27822138 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases